Ion

Advent Technologies Announces Intent with Airbus to Launch a Joint Benchmarking Project

Retrieved on: 
Monday, November 6, 2023
Other Energy, Hardware, Alternative Energy, Energy, Technology, Environment, Green Technology, Engineering, Air, Transport, Other Technology, Aerospace, Manufacturing, Airbus, Knowledge, Ion association, Aviation, ADN, Membrane electrode assembly, Ion, Airline

Airbus will provide financial support to the project and its extensive knowledge of the aviation industry.

Key Points: 
  • Airbus will provide financial support to the project and its extensive knowledge of the aviation industry.
  • Advent will invest in people, materials, hardware, and 3rd party research centers, to contribute to the goals of the project.
  • Dr. Chris Kaskavelis, Chief Strategy Officer of Advent Technologies, commented, “We are pleased to announce that Airbus and Advent have aligned visions and efforts to achieve hydrogen flight.
  • We are excited to join this multi-year project with Airbus.”

Cleaner Air at Your Doorstep: AURA Launches the Ion Bar™, Redefining Indoor Air Quality and Safety

Retrieved on: 
Friday, October 20, 2023
Technology, Retail, Health, Manufacturing, Other Construction & Property, Environmental Health, Home Goods, Construction & Property, Environment, Other Retail, Infectious Diseases, HVAC, General Health, Hardware, Ozone, Pollen, Dust, N-95, SARS-CoV-2, Ion, Human, Smoke, Pet, Carbon, Atmosphere, Virus, Multimedia, COVID-19, Naïs, Safety, Airport, Environmental remediation, Heating, ventilation, and air conditioning

AURA Technologies , an innovative provider of technology solutions for health, safety, security, and national defense, today launched the AURA Ion Bar ™, a groundbreaking new product category in the indoor air quality space.

Key Points: 
  • AURA Technologies , an innovative provider of technology solutions for health, safety, security, and national defense, today launched the AURA Ion Bar ™, a groundbreaking new product category in the indoor air quality space.
  • The Ion Bar™ is the only system in the world that creates a germ-destroying barrier across any two spaces safely using Negative Air Ions (NAIs).
  • “The AURA Ion Bar™ represents a significant leap in air safety technology,” said Anna Bennett, Co-CEO of AURA Technologies.
  • The AURA Ion Bar™ changes this paradigm by instantly deactivating pathogens, ensuring cleaner, healthier air upon entry.

Hoag to Offer Technology to Detect Lung Cancer Earlier and More Accurately

Retrieved on: 
Wednesday, September 6, 2023
CT, Surgeon, Ion, 3D, Lung cancer, Patient, Physician, Risk, Diagnosis, Metastasis, Safety, Biopsy, Medical imaging

NEWPORT BEACH, Calif., Sept. 6, 2023 /PRNewswire/ -- A new lung cancer screening technology is now available at Hoag Family Cancer Institute in Orange County, empowering physicians with greater accuracy in diagnosing lung cancer earlier, when it is most treatable.

Key Points: 
  • NEWPORT BEACH, Calif., Sept. 6, 2023 /PRNewswire/ -- A new lung cancer screening technology is now available at Hoag Family Cancer Institute in Orange County, empowering physicians with greater accuracy in diagnosing lung cancer earlier, when it is most treatable.
  • Hoag is integrating the Cios Spin imaging equipment with the 3D imaging of Hoag's Ion Robotic-Assisted Bronchoscopy to diagnose lung cancer earlier, more accurately and less invasively.
  • "We are offering patients technologies that work together to help diagnose lung cancer earlier and potentially save lives.
  • The technology comes to Hoag thanks to a generous gift by Hoag Innovators , a group of philanthropists, entrepreneurs and community leaders who are dedicated to catalyzing innovation at Hoag.

Equatic’s Transformative Technology Allows Seawater to Capture & Store Carbon

Retrieved on: 
Tuesday, August 15, 2023
Engineering, Other Natural Resources, Environment, Manufacturing, Alternative Energy, Natural Resources, Energy, Heart, Universal Verification Methodology, Bicarbonate, Eco, Climate, Electrolysis, Atmosphere, White paper, Magnesium, ISO, Hope, Noetics, CDR, Seawater, Ion, MRV, CO2, Environmental impact assessment, Lithium, Risk management, Renewable energy, Henderson–Hasselbalch equation

Carbon removal company Equatic has developed a revolutionary process that relies on seawater electrolysis to capture and store carbon dioxide (CO2), while simultaneously producing clean hydrogen.

Key Points: 
  • Carbon removal company Equatic has developed a revolutionary process that relies on seawater electrolysis to capture and store carbon dioxide (CO2), while simultaneously producing clean hydrogen.
  • Continuous, unambiguous data about operational performance can be obtained directly from in-plant measurements of CDR rate and extent.
  • This data-driven approach ensures that the carbon removal process is meticulously monitored and recorded.
  • This makes Equatic’s carbon removal approach a promising contender for tackling the issue of atmospheric carbon accumulation.

Award-Winning Pilates and Wellness Brand Lindywell Launches on Amazon

Retrieved on: 
Wednesday, August 2, 2023
Exercise, Diet, PAH, Pilates, Health, Lead, Women's health, Spine, Robin, Stainless steel, Water, Movement, Capsule, Pesticide, Dioxin, LaTeX, Amazon (company), Ion, BPA, PCB, UCI Trials World Championships – Men's trials, 26 inch, System, Aftermath (Amy Lee soundtrack), Mental health, Hydrocarbon, PVC, Online shopping, Amazon

*

Key Points: 
  • *
    "We are incredibly excited to launch in the world's best-in-class e-commerce retailer," said Robin Long, CEO and Founder of Lindywell.
  • Lindywell's launch includes a dedicated brand store and four of Lindywell's best-selling equipment in Lindywell's signature color palette.
  • Lindywell products available at launch include:
    Pilates Mat : The Lindywell Pilates Powerhouse Mat is the foundation of your workout.
  • Lindywell plans to add more product offerings to its Amazon storefront in the coming months to further equip shoppers with all the tools needed to upgrade workouts and create personal Pilates studios at home.

SCS Technologies Opens Strategy and Innovation Office at The Ion, Houston’s Innovation Hub

Retrieved on: 
Monday, July 31, 2023
Other Manufacturing, Environment, Other Energy, Engineering, Utilities, Oil, Gas, Sustainability, Manufacturing, Green Technology, Energy, Organization, Methane, Carbon accounting, Innovation, GHG, Education, CO2, Global warming potential, Ion, SCS, Renewable energy

SCS Technologies (SCS), a leading provider of CO2 compression and measurement systems, methane vapor recovery units and petroleum LACT units, today announced the company’s new Strategy & Innovation Office at the Ion located in Houston’s innovation district.

Key Points: 
  • SCS Technologies (SCS), a leading provider of CO2 compression and measurement systems, methane vapor recovery units and petroleum LACT units, today announced the company’s new Strategy & Innovation Office at the Ion located in Houston’s innovation district.
  • “Embracing Houston's pivotal role in the energy transition, the Ion has swiftly become the epicenter of innovative collaborations.
  • For SCS Technologies, this marks an exciting opportunity to align our capabilities and technology with a diverse consortium of organizations working toward ambitious carbon-neutral goals,” said Cody Johnson, CEO of SCS Technologies.
  • Many of these visionary partners and clients operate from the Ion, amplifying collaboration and expediting progress toward carbon-neutral efforts.

Thermo Fisher Scientific Introduces New Reproductive Health Assays to Accelerate Fertility Research

Retrieved on: 
Monday, July 17, 2023
Science, Women, Other Science, Research, Health, Medical Devices, Genetics, Consumer, Chromosome, Polyploidy, Probability, Ion, ART, Infertility, Multimedia, Thermo Fisher Scientific, IVF, ICSI, Antibiotics, Dietary supplement, Birth control

To extend the benefits of genomic testing research for reproductive health labs, Thermo Fisher Scientific today launched two new next-generation sequencing-based options to support preimplantation genetic testing-aneuploidy (PGT-A) used commonly to inform in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research.

Key Points: 
  • To extend the benefits of genomic testing research for reproductive health labs, Thermo Fisher Scientific today launched two new next-generation sequencing-based options to support preimplantation genetic testing-aneuploidy (PGT-A) used commonly to inform in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research.
  • The Ion ReproSeq PGT-A Kit * and the Ion AmpliSeq Polyploidy Kit * mark the first research use reproductive health assays available on the Ion Torrent Genexus Integrated Sequencer*, delivering complete workflows from sample to result for aneuploidy analysis.
  • “Building on Thermo Fisher’s existing reproductive health offerings, today’s launch brings the benefits of next-generation sequencing to more research labs with the potential of rapid, in-house testing and analysis,” said Garret Hampton, president, clinical next-generation sequencing and oncology at Thermo Fisher Scientific.
  • “Considering the far-reaching implications for those struggling with infertility, researchers must have reliable and accurate testing available to advance the fertility field and ultimately improve reproductive health for all.

Intlvac Thin Film Expands Research and Development Capabilities

Retrieved on: 
Wednesday, June 14, 2023
Diamond, Carbon, Hydrogen, Doctor of Philosophy, Telecommunications, Ion, DLC, Lead, Medicine, Research, Zinc sulfide, Diamond-like carbon, Zinc selenide, Commercial, MGF, Ge, Nintendo Research & Engineering, Germanium

HALTON HILLS, ON, June 14, 2023 /PRNewswire/ - Intlvac Thin Film, a Canadian advanced manufacturing company that has a thirty-year history in the thin film deposition and materials science industry with clients in the aerospace & defence, medicine, telecommunications, energy, optics and photonics industries is expanding its research and development capabilities at its corporate headquarters in Canada.

Key Points: 
  • HALTON HILLS, ON, June 14, 2023 /PRNewswire/ - Intlvac Thin Film, a Canadian advanced manufacturing company that has a thirty-year history in the thin film deposition and materials science industry with clients in the aerospace & defence, medicine, telecommunications, energy, optics and photonics industries is expanding its research and development capabilities at its corporate headquarters in Canada.
  • Intlvac Thin Film is enhancing its research and development capabilities in Canada and has numerous available positions," announced Intlvac Thin Film President Dino Deligiannis.
  • Our team has been working together for decades to advance thin film deposition, ion beam etching deposition, thin film coatings and Ion sources for surface modifications.
  • "Our recent research and development efforts and expenditures have resulted in commercial success as our Diamond Like Carbon (DLC) coating capabilities are finding applications and are in demand in the defence industry.

Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patent in Japan

Retrieved on: 
Tuesday, June 13, 2023
Intellectual property, Drug development, Therapy, Eurosport 1, G protein-coupled receptor, Ion, SLC, Proteome, Research, Cell, Biotechnology, Patent, Drug discovery, Library, Prosaposin, Membrane, Pharmaceutical industry, EU

STOCKHOLM, Sweden, June 13, 2023 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to announce the issuance of a new patent in Japan for its Salipro® platform technology. The patent, entitled "Saposin lipoprotein particles and libraries from crude membranes," (Japanese Patent No. 7149929) further strengthens Salipro Biotech's leading position in the field of membrane protein research and drug discovery.

Key Points: 
  • Salipro Biotech obtains granted patent in Japan, protecting its proprietary Salipro® platform technology to enable the development of therapeutics against challenging drug targets, including GPCRs, SLCs and Ion Channels.
  • STOCKHOLM, Sweden, June 13, 2023 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to announce the issuance of a new patent in Japan for its Salipro® platform technology.
  • "This patent grant in Japan is an important addition to our global IP portfolio, which already includes granted patents in the U.S., EU, and China," says Jens Frauenfeld, CEO of Salipro Biotech.
  • By expanding the company's intellectual property portfolio, this patent enhances Salipro Biotech's value proposition for collaborations with pharmaceutical companies and its internal pipeline.

Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patent in Japan

Retrieved on: 
Monday, June 12, 2023
Intellectual property, Drug development, Therapy, Eurosport 1, G protein-coupled receptor, Ion, SLC, Proteome, Research, Cell, Biotechnology, Patent, Drug discovery, Library, Prosaposin, Membrane, Pharmaceutical industry, EU

STOCKHOLM, Sweden, June 13, 2023 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to announce the issuance of a new patent in Japan for its Salipro® platform technology. The patent, entitled "Saposin lipoprotein particles and libraries from crude membranes," (Japanese Patent No. 7149929) further strengthens Salipro Biotech's leading position in the field of membrane protein research and drug discovery.

Key Points: 
  • Salipro Biotech obtains granted patent in Japan, protecting its proprietary Salipro® platform technology to enable the development of therapeutics against challenging drug targets, including GPCRs, SLCs and Ion Channels.
  • STOCKHOLM, Sweden, June 13, 2023 (GLOBE NEWSWIRE) -- Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to announce the issuance of a new patent in Japan for its Salipro® platform technology.
  • "This patent grant in Japan is an important addition to our global IP portfolio, which already includes granted patents in the U.S., EU, and China," says Jens Frauenfeld, CEO of Salipro Biotech.
  • By expanding the company's intellectual property portfolio, this patent enhances Salipro Biotech's value proposition for collaborations with pharmaceutical companies and its internal pipeline.